TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,050 | +50.2% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $699 | -30.1% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 700 | -17.6% | 0.00% | – |
| Q4 2021 | $4,000 | -89.5% | 850 | -81.1% | 0.00% | – |
| Q3 2021 | $38,000 | -89.9% | 4,506 | -80.3% | 0.00% | -100.0% |
| Q2 2021 | $375,000 | -25.3% | 22,874 | +0.7% | 0.00% | 0.0% |
| Q1 2021 | $502,000 | -24.3% | 22,724 | +6.1% | 0.00% | 0.0% |
| Q4 2020 | $663,000 | +4635.7% | 21,415 | +2959.3% | 0.00% | – |
| Q3 2020 | $14,000 | +27.3% | 700 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | +120.0% | 700 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -16.7% | 700 | +75.0% | 0.00% | – |
| Q4 2019 | $6,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |